Search research articles
Contact Us
Filters
Showing results (71-80 of 132) with videos related to
Page
of 14
Sort By:
Urologic Oncology
|
January 14, 2023
Editorial: Cutting edge basic and clinical bladder cancer research - the IBCN updates
Peter J Goebell, Ashish M Kamat, Peter C Black, et al.
The Journal of Urology
|
April 24, 2016
Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures
Roland Seiler, Lucia L Lam, Nicholas Erho, et al.
BMC Urology
|
May 11, 2023
Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial
Roland Seiler, Martin Egger, Marta De Menna, et al.
European Urology
|
May 4, 2012
Occlusion of seminal vesicles increases sexual activity in a mouse model
Frédéric D Birkhäuser, Celine Schumacher, Roland Seiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapy
Joep J de Jong, Moritz J Reike, Yair Lotan, et al.
Scientific Reports
|
March 13, 2021
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer
Friedemann Krentel, Franziska Singer, María Lourdes Rosano-Gonzalez, et al.
Urologic Oncology
|
March 11, 2019
New horizons in bladder cancer research
Joost L Boormans, Ellen C Zwarthoff, Peter C Black, et al.
The Journal of Urology
|
June 7, 2015
Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer
Tetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, et al.
BJU International
|
August 21, 2021
A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer
Marc A Furrer, Nathan Papa, Sandro Luetolf, et al.
European Urology Focus
|
May 8, 2021
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer
Moritz Maas, Steffen Rausch, Teresa Guttenberg, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 132) with videos related to
Sort By:
Page
of 14
Urologic Oncology
|
January 14, 2023
Editorial: Cutting edge basic and clinical bladder cancer research - the IBCN updates
Peter J Goebell, Ashish M Kamat, Peter C Black, et al.
The Journal of Urology
|
April 24, 2016
Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures
Roland Seiler, Lucia L Lam, Nicholas Erho, et al.
BMC Urology
|
May 11, 2023
Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial
Roland Seiler, Martin Egger, Marta De Menna, et al.
European Urology
|
May 4, 2012
Occlusion of seminal vesicles increases sexual activity in a mouse model
Frédéric D Birkhäuser, Celine Schumacher, Roland Seiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapy
Joep J de Jong, Moritz J Reike, Yair Lotan, et al.
Scientific Reports
|
March 13, 2021
A showcase study on personalized in silico drug response prediction based on the genetic landscape of muscle invasive bladder cancer
Friedemann Krentel, Franziska Singer, María Lourdes Rosano-Gonzalez, et al.
Urologic Oncology
|
March 11, 2019
New horizons in bladder cancer research
Joost L Boormans, Ellen C Zwarthoff, Peter C Black, et al.
The Journal of Urology
|
June 7, 2015
Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer
Tetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, et al.
BJU International
|
August 21, 2021
A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer
Marc A Furrer, Nathan Papa, Sandro Luetolf, et al.
European Urology Focus
|
May 8, 2021
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder Cancer
Moritz Maas, Steffen Rausch, Teresa Guttenberg, et al.
Page
of 14